書籍詳細

第1章 膠原病と肺病変

P.23 掲載の参考文献

• 1) Kim E J, et al : Rheumatoid arthritis-associated interstitial lung disease : the relevance of histopathologic and radiographic pattern. Chest 136 : 1397-1405, 2009.
  pubmed

• 2) Doyle T J, et al : A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease. Chest 145 : 454-463, 2014.
  pubmed

• 3) Dawson J K, et al : Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 56 : 622-627, 2001.
  pubmed

• 4) Koduri G, et al : Interstitial lung disease has apoor prognosis in rheumatoid arthritis : results from an inception cohort. Rheumatology (Oxfbrd) 49 : 1483-1489, 2010.

• 5) Bongartz T, et al : Incidence and mortality of interstitial lung disease in rheumatoid arthritis : a population-based study. Arthritis Rheum 62 : 1583-1591, 2010.
  pubmed

• 6) Olson A L, et al : Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183 : 372-378, 2011.
  pubmed

• 7) Yousem S A, et al : Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131 : 770-777, 1985.
  pubmed

• 8) Lee H K, et al : Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127 : 2019-2027, 2005.
  pubmed

• 9) Yoshinouchi T, et al : Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 26 : 121-125, 2005.
  pubmed

• 10) Park I N, et al : Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132 : 214-220, 2007.
  pubmed

• 11) Nakamura Y, et al : Rheumatoid lung disease : Prognostic analysis of 54 biopsy-proven cases. Respir Med 106 : 1164-1169, 2012.
  pubmed

• 12) Solomon J J, et al : Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med 107 : 1247-1252, 2013.
  pubmed

• 13) Suda T, et al : Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 103 : 846-853, 2009.
  pubmed

• 14) Kono M, et al : Usual interstitial pneumonia preceding collagen vascular disease : a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLos One 9 : e94775, 2014.
  pubmed

• 15) Tanaka N, et al : Rheumatoid arthritis-related lung diseases : CT findings. Radiology 232 : 81-91, 2004.
  pubmed

• 16) Kim E J, et al : Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35 : 1322-1328, 2010.
  pubmed

• 17) Hozumi H, et al : Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease : a retrospective case control study. BMJ Open 3 : eOO3132, 2013.
  pubmed

• 18) Kelly C A, et al : Rheumatoid arthritis-related interstitial lung disease : associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study. Rheumatology (Oxford), 2014.
  pubmed

• 19) Park J H, et al : Prognosis of fibrotic interstitial pneumonia : idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175 : 705-711, 2007.
  pubmed

• 20) Tsuchiya Y, et al : Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome, Eur Respir J 37 : 1411-1417, 2011.
  pubmed

• 21) Assayag D, et al : Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology 19 : 493-500, 2014.

• 22) Izumiyama T, et al : Frequency of bronchobronchiolar disease in rheumatoid arthritis : an examination by high-resolution computed tomography. Mod Rheumatol 12 : 311-317, 2002.
  pubmed

• 23) Mori S, et al : Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus Iongstanding rheumatoid arthritis. J Rheumatol 35 : 1513-1521, 2008.
  pubmed

• 24) Howling S J, et al : Follicular bronchiolitis : thin-section CT and histologic findings. Radiology 212 : 637-642, 1999.
  pubmed

• 25) Muller N L, et al : Diseases of the bronchioles : CT and histopathologic findings. Radiology 196 : 3-12, 1995.
  pubmed

• 26) Hayakawa H, et al : Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease : similarities and differences. Intern Med 37 : 504-508, 1998.
  pubmed

• 27) Swinson D R, et al : Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol 36 : 689-691, 1997.
  pubmed

• 28) 高柳昇, 他 : 関節リウマチに合併した肺感染症の検討. 日呼吸会誌 45 : 465-473, 2007.
  Medical*Online

• 29) Hayakawa H, et al : Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 154 : 1531-1536, 1996.
  pubmed

P.32 掲載の参考文献

• 1) 末松栄一, 他 : 膠原病に合併した間質性肺炎における血清マーカーKL-6およびSP-Dの臨床的検討. リウマチ 43 (1) : 11-18, 2003.

• 2) Ihn H, et al : Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis : collelation with interstitial lung disease. Rheumatol 41 : 1268-1272, 2002.

• 3) Tanizawa K, et al : The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 107 : 745-752, 2013.
  pubmed

• 4) Huh J W, et al : Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101 : 1761-1769, 2007.

• 5) Travis W D, et al : An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013.
  pubmed

• 6) Connors G R, et al : Interstitial lung disease associated with the idiopathic inflammatory myopathies. What progress has been made in the past 35 years? Chest 138 : 1464-1474, 2010.
  pubmed

• 7) Douglas W W, et al : Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164 : 1182-1185, 2001.
  pubmed

• 8) Mimori T, et al : Autoantibodies in idiopathic infiammatory myopathy : an update on clinical and pathophysiological significance, Curr Opin Rheumatol 19 : 523-529, 2007.

• 9) Sato S, et al : Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52 : 1571-1576, 2005.
  pubmed

• 10) Kato H, et al : Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 : 101-105, 2006.
  pubmed

• 11) Ye S, et al : Adults clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease : a retrospective cohort study. Clin Rheumatol 26 : 1647-1654, 2007.
  pubmed

• 12) Mukae H, et al : Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136 : 1341-1347, 2009.
  pubmed

• 13) Nagasaka K, et al : Efficacy of combination treatment with cyclosporine A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatol 13 : 231-238, 2003.

• 14) Kotani T, et al : Early intervention with corticosteroids and cyclosporine A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J Rheumatol 35 : 254-259, 2008.
  pubmed

• 15) Fujisawa T, et al : Prognostic factors for myositis-associated interstitial lung disease. PLOS ONE 9 : e98824, 2014.
  pubmed

• 16) Sun Y, et al : Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients : a retrospective study of 41 chinese han patients. Rheumatol Int 33 : 1295-1302, 2013.
  pubmed

• 17) Gono T, et al : Anti-MDA5 antibody, ferritin and IL-18 are useful fbr the evaluation of response to treatment in interstitial lung disease with anti-MDAs antibody-positive dermatomyositis. Rheumatology 51 : 1563-1570, 2012.

• 18) Serium interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Mod Rheumatol 24 : 633-636, 2014.

• 19) Suzuki Y, et al : Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis. Lung 187 : 201-206, 2009.
  pubmed

P.41 掲載の参考文献

• 1) LeRoy E C, et al : Scleroderma (systemic sclerosis) : classification, subsets and pathogenesis. J Rheumatol 15 : 201-204, 1988.

• 2) Solomon J J, et al ; Scleroderma lung disease. Eur Res Rev 22 (127) : 6-19, 2013.

• 3) Erica L, et al : Interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis. Arthritis Rheum 66 : 1967-1978, 2014.

• 4) Schurawitzki H, et al : Interstitial lung disease in progressive systemic sclerosis : high-resolution CT versus radiography. Radiology 176 : 755-759, 1990.
  pubmed

• 5) Steen V D, et al : Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 28 : 759-767, 1985.
  pubmed

• 6) McNearney T A, et al : Pulmonary involvement in systemic sclerosis : associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 57 : 318-326, 2007.
  pubmed

• 7) Hamaguchi Y, et al : The clinical relevance of serum antinuclear antibodies in Japanease patients with systemic sclerosis. Br J Dermatol 158 : 487-495, 2008.

• 8) Goldin J G, et al : High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134 : 358-367, 2008.
  pubmed

• 9) 桑名正隆 : 全身性硬化症 (強皮症). 間質性肺疾患診療マニュアル (久保恵嗣, 他監) p228-233. 南江堂, 東京, 2010.

• 10) Morgan C, et al : Predictors of end stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 62 : 146-150, 2003.

• 11) Remy-Jardin M, et al : Pulmonary involvement in progressive systemic sclerosis : sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 188 : 499-506, 1993.
  pubmed

• 12) Strange C, et al : Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 177 : 91-98, 2008.
  pubmed

• 13) 桑名正隆 : 重症度分類・治療指針 (4) 肺. 強皮症における診断基準・重症度分類・治療指針 2007改訂版 (竹原和彦, 他監) p13-19. 2007.

• 14) Teixeira L, et al : Mortality and risk factors of scleroderma renal crisis : a French retrospective study of 50 patients. Ann Rheum Dis 67 : 110-116, 2008.
  pubmed

• 15) Tashkin D, et al : Cyclophosphamide versus Placebo in Sclerodera Lung Disease. N Engl J Med 354 : 2655-2666, 2006.
  pubmed

• 16) Hoyles R K, et al : A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54 : 3962-3970, 2006.
  pubmed

P.50 掲載の参考文献

• 1) Kim J S, et al : Thoracic Involvement of Systemic Lupus Erythematosus : Chnical, Pathologic, and Radiologic Findings. J Comput Assist Tomogr 24 : 9-18, 2000,

• 2) Orens J B, et al : Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 20 : 159-193, 1994.
  pubmed

• 3) Wiedemann H P, et al : Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imag 7 : 1-18, 1992.

• 4) Hunder G G, et al : Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med 76 : 357-363, 1972.
  pubmed

• 5) Bulgrin J G, et al : Chest roentgenographic changes in systemic lupus erythematosus. Radiology 74 : 42-49, 1960.
  pubmed

• 6) Purnel D, et al : Pulmonary lesions in disseminated lupus erythematosus. Ann Intern Med 42 : 619-628, 1955.

• 7) Gross M, et al : Pulmonary alterations in systemic lupus erythematosus. Am Rev Resir 105 : 572-577, 1972.

• 8) Mintz G, et al : Acute massive pulmonary hemorrhage in systemic lumps erythematosus. J Rheumatol 5 : 339-340, 1978.

• 9) Haupt H, et al : The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 71 : 791-798, 1981.
  pubmed

• 10) 吉田正 : SLEと肺胞出血. 医のあゆみ 176 : 294-299, 1996.
  Medical*Online

• 11) Eisenberg H, et al : Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 79 : 37-45, 1973.
  pubmed

• 12) Lynch J P III, et al : Pulmonary complications of collagen vascular disease. Ann Rheum Med 43 : 17-35, 1992.

• 13) Gammon R B, et al : Bronchiolitis obliterans organizing Pneumonia associated with systemic lupus erythematosus. Chest 102 : 1171-1174, 1992.
  pubmed

• 14) Lee K S, et al : Cryptogenic organizing pneumonia : CT findings in 43 patients. AJR 162 : 543-546, 1994.
  pubmed

• 15) Teitel A D, et al : Laryngeal involvement in systemic lupus erythematosus, Semin Arthritis Rheum 22 : 203-214, 1992.
  pubmed

• 16) Keane M P, et al : Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 55 : 159-166, 2000.
  pubmed

• 17) Sanchez O, et al : Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130 : 182-189, 2006.
  pubmed

• 18) 桑名正隆 : 膠原病に伴う肺高血圧症. 呼と循環 61 : 1117-1122, 2013.

• 19) 白井悠一郎, 他 : 膠原病性肺高血圧症の治療も進歩・整理されてきました. Heart View 17 : 770-775, 2013.
  Medical*Online

• 20) Shirai Y, et al : Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension : a single-centre cohort. Rheumatology 51 : 1846-1854, 2012.
  pubmed

• 21) Barst R J, et al : Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 54 : S78-84, 2009.
  pubmed

P.58 掲載の参考文献

• 1) Ito I, et al : Pulmonary manifestations of primary Sjogren's syndrome : a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171 (6) : 632-638, 2005.
  pubmed

• 2) Sjogren症候群. ハリソン内科学第4版 (福井次夫, 他訳) p2394-2397. メディカルサイエンスインターナショナル, 東京, 2013.

• 3) Yamadori I, et al : Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren's syndrome. Rheumatol Int 22 : 89-92, 2002.
  pubmed

• 4) Koyama M, et al : Pulmonary involvement in primary Sjogren's syndrome : spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 16 (4) : 290-296, 2001.
  pubmed

• 5) Bertoni M, et al : Pulmonary hypertension in primary Sjogren's syndrome : report of a case and review of the literature. Clin Rheumatol 24 : 431-434, 2005.
  pubmed

• 6) 山本元久 : ミクリッツ病. 肝胆膵 64 (1) : 83-90, 2012.
  Medical*Online

• 7) Umehara H, et al : Comprehensive diagnostic criteria fbr IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22 (1) : 21-30, 2012.

• 8) Keir G J, et al : Rituximab in severe, treatment-refractory interstitial lung disease. Respirology 19 (3) : 353-359, 2014.

• 9) Keir G J, et al : Severe interstitial lung disease in connective tissue disease : rituximab as rescue therapy. Eur Respir J 40 (3) : 641-648, 2012.
  pubmed

• 10) Enomoto Y, et al : Prognostic factors in interstitial Iung disease associated with primary Sjogren's syndrome : a retrospective analysis of 33 pathologically-proven cases. PLoS One 8 (9) : e73774, 2013.

P.66 掲載の参考文献

• 1) Sharp G C, et al : Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA), Am J Med 52 (2) : 148-159, 1972.

• 2) 粕川禮司 : 混合性結合組織病の診断の手引き. 厚生省特定疾患, 混合性結合組織病調査研究班, 昭和58年度研究報告書, p75-82. 1985.

• 3) 近藤啓文 : 厚生労働省科学研究費補助金難治性疾患克服研究事業混合性結合組織病に関する研究班, 平成14年度〜16年度総合研究報告書, p1-10. 2005.

• 4) Travis W D, et al : An official American Thoracic Society/European Respiraory Society Statements : Update of the International Multidisciplinary Classification of the Idiopathic interstitial Pneumonias. Am J Respir Crit Care Med 188 (6) : 733-748, 2013.

• 5) Saito Y, et al : Pulmonary involvement in mixed connective tissue disease : comparison with other collagen vascular disease using high resolution CT. J Comput Assist Tomogr 26 (3) : 349-357, 2002.
  pubmed

• 6) 近藤啓文 : 厚生労働省科学研究費補助金難治性疾患克服研究事業混合性結合組織病の臨床経過についてのプロジェクト研究-MCTDと他の膠原病の比較-厚生省特定疾患皮膚・結合織疾患調査研究班混合性結合組織病分科会, 平成10年度研究報告書, p11-14. 1999.

• 7) Gunnarsson R, et al : Prevalence and severity of interstitial lung disease in mixed connective tissue disease : a nationwide, cross-sectional study. Ann Rheum Dis 71 (12) : 1966-1972, 2011.

• 8) 小谷卓矢, 他 : 全身性強皮症に伴う間質性肺炎の臨床・画像・治療. 日胸臨 69 (3) : 199-209, 2010.
  Medical*Online

• 9) Simonneau G, et al : Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62 (25suppl) : D34-41, 2013.

• 10)Tanaka S, et al : Determination of the accurate incidence of pulmonary arterial hypertension in patients with systemic sclerosis, mixed connective tissue disease and systemic lupus erythematosus by prospective study for 3-years. Arthrirtis Rheum 62 (suppl) : S237, 2010.

• 11) Condliffe R, et al : Connective tissue-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179 (2) : 151-157, 2009.
  pubmed

• 12) Chung L, et al : Characterization of connective tissue-associated pulmonary arterial hypertension from REVEAL : Identifying systemic sclerosis as a unique phenotype. Chest 138 (6) : 1383-1394, 2010.
  pubmed

• 13) Jeon C H, et al : Pulmonary hypertension associated with rheumatic diseases : baseline characteristics from the Korean registry. Int J Rheum Dis 15 (5) : e80-e89, 2012.
  pubmed

• 14) Shirai Y, et al : Clinical characterization and survival of Japanese patients with connective disease and pu1monary arterial hypertension : a single-centre cohort. Rheumatology 51 (10) : 1846-1854, 2012.

• 15) Sanchez O, et al : ImmunosupPressive therapy in connective tissue disease-associated pulmonary arterial hypertension. Chest 130 (1) : 182-186, 2006.
  pubmed

• 16) Jais X, et al : Immunosuppressive therapy in lupus-and mixed connective tissue-associated pulmonary arterial hypertension. Arthritis Rheum 58 (2) : 521-531, 2008.
  pubmed

第2章 血管炎と肺病変

P.71 掲載の参考文献

• 1) Jennette J C, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013.

• 2) Dolman K M, et al : Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342 : 651-652, 1993.
  pubmed

• 3) Gao Y, et al : Long-term outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxfbrd) 47 : 1515-1520, 2008.

• 4) Sera N et al : Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid 10 : 595-599, 2000.
  pubmed

• 5) 真木山八城, 他 : Propylthiouracil内服中に発症したMPO-ANCA陽性肺胞出血の1例. 日呼吸会誌 38 (3) : 201-205, 2000.
  Medical*Online

• 6) 佐田憲映, 他 : 臨床個人調査票を用いた難治性血管炎治療における診療行動解析. 厚生労働科学研究費補助金難治性疾患克服研究事業難治性血管炎に関する調査研究平成21年度総括・分担研究報告書, p100-101. 2010.

• 7) 天野宏一, 他 : アレルギー性肉芽腫性血管炎 (Churg Strauss症候群) の本邦における実態解明に関する研究. 厚生労働科学研究費補助金難治性疾患克服研究事業難治性血管炎に関する調査研究平成21年度総括・分担研究報告書, p98-99. 2010.

• 8) Zamora M R, et al : Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 76 : 192-202, 1997.
  pubmed

• 9) Mansi I A, et al : Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis : is anti-neutrophilic cytoplasmic antibody testing indicated? Am J Med Sci 321 : 201-202, 2001.
  pubmed

• 10) Nozu T, et al : A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 77 : 407-415, 2009.
  pubmed

• 11) Lohrmann C, et al : Pulmonary manifestations of wegener granulomatosis : CT findings in 57 patients and a review of the literature. Eur J Radiol 53 : 471-477, 2005.

• 12) Kim Y K, et al : Pulmonary involvement in Churg-Strauss syndrome : an analysis of CT, clinical, and pathologic findings. Eur Radiol 17 : 3157-3165, 2007.
  pubmed

• 13) Mukhtyar C, et al : Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68 : 1827-1832, 2009.
  pubmed

• 14) Mukhtyar C, et al : EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68 : 310-317, 2009.
  pubmed

• 15) Martinez V, et al : Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies : results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum 58 : 308-317, 2008.
  pubmed

• 16) Jones RB, et al : Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363 : 211-220, 2010.
  pubmed

P.78 掲載の参考文献

• 1) Goodpasture E W, et al : The significance of certain pulmonary lesions in relation to the etiology of influnenza. Am J Med Sci 158 : 863-870, 1919.

• 2) Dammacco F, et al : Goodpasture's disease : a report of ten cases and a review of the literature. Autoimmun Rev 12 (11) : 1101-1108, 2013.

• 3) Ang C, et al : Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant 13 (4) : 935-939, 1998,
  pubmed

• 4) Zhao J, et al : The immunoglobulin G subclass distribution of anti-GBM autoantibodies against a3 (IV) NCl is associated with disease severity. Hum Immunol 70 (6) : 425-429, 2008.

• 5) Levy J B, et al : Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66 (4) : 1535-1540, 2004.
  pubmed

• 6) Bosch X, et al : Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 36 (3) : 107-113, 1991.
  pubmed

• 7) Pedchenko V, et al : Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363 (4) : 343-354, 2010.
  pubmed

• 8) DE Zoysa J, et al : Incidence and features of dual anti-GBM-positive and ANCA-positive patients. Nephrology (Carlton) 16 (8) : 725-729, 2011.
  pubmed

• 9) Levy J B, et al : Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134 (11) : 1033-1042, 2001.
  pubmed

• 10) Syeda U A, et al : Anti-glomerular basement membrane antibody disease treated with rituximab : A case-based review. Semin Arthritis Rheum 42 (6) : 567-572, 2013.
  pubmed

P.87 掲載の参考文献

• 1) 松尾清一, 他編 : 急速進行性腎炎症候群の診療指針第2版. 厚労労働省特定疾患進行性腎障害に関する調査研究班報告. 日腎会誌 53 : 509-555, 2011.

• 2) Yamagata K, et al : Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey. Clin Exp Nephrol 17 (5) : 646-649, 2013.

• 3) 有村義宏, 他 : ANCA関連血管炎とRPGN. 日腎会誌 51 : 88-93, 2009.

• 4) 有村義宏 : 内科医が知っておくべき腎臓と全身臓器とのインターラクション 1) 肺と腎臓.日内会誌 100 : 2530-2536, 2011.

• 5) West S C, et al : Pulmonary-renal syndrome : a life threatening but treatable condition. Postgrad Med J 89 (1051) : 274-283, 2013.
  pubmed

• 6) 臼井丈一, 他 : 我が国のRPGNの現状と将来の展望. 日腎会誌 51 : 78-73, 2009.

• 7) 藤元昭一 : RPGN, ANCA関連血管炎の疫学. 日腎会誌 51 : 84-87, 2009.

• 8) 清水芳男, 他 : 抗糸球体抗体型腎炎とRPGN. 日腎会誌 51 : 94-97, 2009.

• 9) 古城昭一郎, 他 : 免疫複合体型腎炎とRPGN. 日腎会誌 51 : 98-102, 2009.

• 10) 中西浩一, 他 : 小児科領域のRPGN. 日腎会誌 51 : 102-106, 2009.

• 11) Jennette J C, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 (1) : 1-11, 2013.

• 12) 平山浩一, 他 : RPGNの治療 日腎会誌 51 : 107-113, 2009.

• 13) 吉田雅治 : 腎機能障害を考慮した免疫抑制薬の使用法, 感染症対策. 日腎会誌 51 : 114-120, 2009.

P.94 掲載の参考文献

• 1) Wegener F : Uber generalisiertte, septishe Gefasserkrankungen. Verh Dtsch Pathol Ges Pathol 29 : 202-210, 1936.

• 2) Wegener F : Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und Nieren. Beitr Pathol Anat 102 : 36-68, 1939.

• 3) Jennette J C, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013.

• 4) Kallenberg C G M : Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 : 29-36, 2008.
  pubmed

• 5) Stegeman C A, et al : Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335 : 16-20, 1996.
  pubmed

• 6) LeaVitt R Y, et al : The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33 : 1101, 1990.
  pubmed

• 7) 松原修 : 炎症と腫瘍の境界Wegener肉芽腫症における多彩な肺の病理像. 日胸臨 56 : 634-640, 1997.

• 8) Gross W L, et al : Antineutrophil cytoplasmic autoantibody-associated diseases : a rheumatologist's perspective. Am J Kidney Dis 18 : 175-179, 1991.

• 9) Kerr G S, et al : Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36 : 365-371, 1993.
  pubmed

• 10) Seo J B, et al : Pulmonary vasculitis : the spectrum of radiological findings. Br J Radiol 73 : 1224-1231, 2000.
  pubmed

• 11) Thickett D R, et al : Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis. Rheumatology (Oxford) 45 : 261-268, 2006.
  pubmed

• 12) Colby T V : Diffuse pulmonary hemorrhage in Wegener's granulomatosis. Semin Respir Med 10 : 136, 1989.

• 13) Ananthakrishnan L, et al : Wegener's granulomatosis in the chest : high-resolution CT findings. AJR Am J Roentgenol 192 : 676-682, 2009.
  pubmed

• 14) Mark E J, et al : The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis : a study based on 35 Open lung biopsies. Hum Pathol 19 : 1065-1071, 1989.

• 15) 松原修他 : Wegener肉芽腫症の肺生検による病理組織学的診断に関する検討. 呼吸 15 : 1033-1039, 1996.
  Medical*Online

• 16) Yousem S A : Bronchocentric inj ury in Wegener's granulomatosis : a report of five cases. Hum Pathol 22 : 535-540, 1991.

• 17) Yousem S A, et al : The eosinophilic variant of Wegener's granulomatosis. Hum Pathol 19 : 682-688, 1988.

• 18) Uner A H, et al : Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. Am J Surg Pathol 20 : 794-801, 1996.
  pubmed

• 19) Mark E J, et al : Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 109 : 413-418, 1985.
  pubmed

• 20) Yoshimura N, et al : Wegener's granulomatosis. Associated with diffuse pulmonary hemorrhage. Acta Pathol Jpn 42 : 657-661, 1992.
  pubmed

• 21) Luqmani R A, et al : Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis 87 : 671-678, 1994.
  pubmed

• 22) Mukhtyar C, et al : EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68 : 310-317, 2009.
  pubmed

• 23) Stone JH, et al : Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363 : 221-232, 2010.
  pubmed

• 24) Jones RB, et al : Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis, N Engl J Med 363 : 211-220, 2010.
  pubmed

• 25) Nachman P H, et al : Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7 : 33-39, 1996.
  pubmed

• 26) Hoffman G S : Wegener's granulomatosis. Curr Opin Rheumatol 5 : 11-17, 1993.
  pubmed

• 27) Tomasson G, et al : Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis. Rheumatology (Oxford) 51 : 100-109, 2012.
  pubmed

第3章 血液疾患による肺病変

P.102 掲載の参考文献

• 1) Chaoui D, et al : Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 18 (4) : 670-675, 2004.
  pubmed

• 2) Tenholder M F, et al : Pulmonary infiltrates in leukemia. Chest 78 (3) : 468-473, 1980.
  pubmed

• 3) 中山雅之, 他 : 血液疾患に合併した胸部異常陰影に対する気管支鏡検査の有用性. 気管支学 28 (4) : 278-283, 2006.
  Medical*Online

• 4) Papin T A, et al : Transbronchial biopsy in the thrombocytopenic patient. Chest 88 (4) : 549-552, 1985.
  pubmed

• 5) Freifeld A G, et al : Clinical practice guideline fbr the use of antimicrobial agents in neutropenic patients with cancer : 2010 Update by the Infectious Diseases Society of America., Clin Infect Dis 52 (4) : 427-431, 2011.

• 6) Ganzel C, et al : Hyperleukocytosis, leukostasis and leukapheresis : practice management Blood Rev 26 (3) : 117-122, 2012.
  pubmed

• 7) Ohnishi K, et al : Twenty-seven cases of drug-induced interstitial lung diseases associated with imatinib mesylate. Leukemia 20 (6) : 1162-1164, 2006.
  pubmed

• 8) Valent P : Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors : preferential occurrence in patients with comorbidities. Haematologica 96 (10) : 1395-1397, 2011.
  pubmed

• 9) Ohnishi H, et al : Circulating KL-6 levels in patients with drug induced pneumonitis. Thorax 58 (10) : 872-875, 2003.
  pubmed

• 10) Vlaar A P, et al : Transfusion-related acute lung injury : a clinical review. Lancet 382 (9896) : 984-994, 2013.
  pubmed

• 11) Panoskaltsis-Mortari A, et al : An official American Thoracic Society research statement : noninfectious lung injury after hematopoietic stem cel transplantation : idiopathic pneumonia syndrome. Am J Respir Crit Care Med 183 (9) : 1262-1279, 2011.

• 12) Williams K M, et al : Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 302 (3) : 306-314, 2009.
  pubmed

P.110 掲載の参考文献

• 1) Guinee D G Jr : Update on nonneoplastic pulmonary lymphoproliferative disorders and related entities. Arch Pathol Lab Med 134 (5) : 691-701, 2010.
  pubmed

• 2) Katzenstein A-L A, et al : Systemic diseases involving the lung. In : Katzenstein and Askin's Surgical Pathology of Non-Neo-plastic Lung Disease. 4th ed (Katzenstein A-LA, ed). p187-215. Elsevier Saunders, Philadelphia PA, 2006.

• 3) American Thoracic Society, European Respiratory Society. AmericanThoracic Society/European Respiratory Society international multidisciplinary consensus classbication of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002.
  pubmed

• 4) William J, et al : Lymphoproliferative Neoplasms of the Lung A Review. Arch Pathol Lab Med 137 : 382-391, 2013.

• 5) 酒井文和, 他 : びまん性肺疾患としての悪性リンパ腫-その画像-. 日呼吸誌 2 (5) : 491-497, 2013.

• 6) 久慈一英, 他 : 悪性リンパ腫の核医学診断-FDG-PETを中心に-肺のリンパ腫MALTリンパ腫, 転移性リンパ腫. 日胸臨 70 (6) : 578-588, 2011.

• 7) Steinfort D P, et al : Endobronchial ultrasound-guided transbronchial needle aspiration for the evaluation of suspected lymphoma. J Thorac Oncol 5 : 804-809, 2010.
  pubmed

• 8) Philippe B, et al : B-cell pulmonary lymphoma : gene rearrangement analysis of bronchoalveolar lymphocytes by polymerase chain reaction. Chest 115 : 1242-1247, 1999.
  pubmed

• 9) Cadranel J, et al : Primary pulmonary lymphoma. Eur Respir J 20 (3) : 750-762, 2002.
  pubmed

• 10) Swerdlow S H, et al : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Fourth Edition. IARC Press, Lyon, France, 2008.

• 11) Isaacson P, et al : Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma, Cancer 52 (8) : 1410-1416, 1983.
  pubmed

• 12) Neri N, et al : Diffuse large B-cell lymphoma primary of lung. Hematology 16 (2) : 110-112, 2011.
  pubmed

• 13) Lim J K, Kurtir, et al : Pulmonary marginal zone lymphoma of MALT type as a cause of localized pulmonary amyloidosis. J Clin Pathol 54 : 642-646, 2001.

• 14) Katzenstein A L, et al : Lymphomatoid granulomatosis : insights gained over 4 decades. Am J Surg Pathol 34 (12) : e35-e48, 2010.
  pubmed

• 15) Ferreri A J, et al : lnternational Extranodal Lymphoma Study Group (IELSG). Intravascular lymphoma : clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 127 (2) : 173-183, 2004.

• 16) Colby T V : Malignancies in the lung and pleura mimicking benign process. SemDiag Pathol 12 : 30-44, 1995.
  pubmed

• 17) Shimada K, et al : Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan. J Clin Oncol 26 (19) : 3189-3195, 2008.

• 18) Minomo S, et al : Primary pulmonary T-cell lymphoma in a human T-lymphotropic virus type-1 carrier showing atypical shadow. J Thorac Oncol 5 (4) : 558-559, 2010.

• 19) Paranjothi S, et al : Lymphoproliferative disease after lung transplantation : comparison of presentationand outcome of early and late cases. J Heart Lung Transplant 20 (10) : 1054-1063, 2001.

• 20) Kamel O W, et al : Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328 (18) : 1317-1321, 1993.
  pubmed

P.117 掲載の参考文献

• 1) Castleman B, et al : Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9 : 822-830, 1956.
  pubmed

• 2) Keller A R et al : Hyaline-vascular and plasma cell types of giant lymph node hyaperplasia of the mediastinum and other locations. Cancer 29 : 670-683, 1972.
  pubmed

• 3) Chen K T K : Multicentiric Castleman's disease and Kaposi's sarcoma. Am J Surg Pathol 8 : 287-293, 1984.

• 4) Soulier J, et al : Kaposi's sarcomarassociated herpes virus like DNA sequences in multicentiric Castleman disease. Blood 86 : 1276-1280, 1995.
  pubmed

• 5) Nicholas J, et al : Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3 : 287-292, 1997.
  pubmed

• 6) 木花いづみ, 他 : 全身性形質細胞増多症. 臨皮 45 : 189-195, 1991.

• 7) 中村敬哉, 他 : Plasma cell interstitial pneunoinaの1例-他中心型Castleman病の肺病変として-. 日胸疾会誌 35 : 776-783, 1997.

• 8) Nishimoto N, et al : Mechanism and pathologic Significance in increase in Serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood 112 : 3959-3964, 2008.
  pubmed

• 9) Johkoh T, et al : Intratharacic multicentiric Castleman disease : CT findings in 12 patients. Radiol 209 : 477-481, 1998.

• 10) 山洞純一, 他 : Multicentiric Castleman's diseaseの胸部画像所見はリンパ節腫脹と間質性肺炎や胸水貯留である. 臨放 44 (1) : 147-152, 1999.

• 11) 森貴紀, 他 : 胸水で発見されたIdiopathic plasmacytic lymphadenopathyの1例. 日呼吸会誌 38 : 288-292, 2000.

• 12) Weisenburger D D, et al : Multicentric angiofollicular lymph node hyperplasia : A clinicopathologic study of 16 cases. Hum Pathol 16 : 162-172, 1985.
  pubmed

• 13) Frizzera G, et al : A systemic lymphoproliferative disorder with morphologic features of CD : Clinical findings and clinicopathologic correlations in l5 patients. J Clin Oncol 3 : 1202-1216, 1985.

• 14) Dupin N, et al : HHV-8 is associated with a plasmablastic variant of CD that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95 : 1406-1412, 2000.
  pubmed

• 15) Nishimoto N, et al : Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman's disease. Blood 106 : 2627-2632, 2005.

P.125 掲載の参考文献

• 1) Umehara H, et al : A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details. Mod Rheumatol 22 : 1-14, 2012.
  pubmed

• 2) Hamano H, et al : High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344 : 732-738, 2001.
  pubmed

• 3) Masaki Y, et al : Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome : analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 68 : 1310-1315, 2009.
  pubmed

• 4) Umehara H, et al : Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22 : 21-30, 2012.
  pubmed

• 5) Matsui S, et al : Respiratory involvement in IgG4-related Mikulicz’s disease. Mod Rheumatol 22 : 31-39, 2012.

• 6) Matsui S, et al : Immunoglobulin G4-related lung disease : clinicoradiological and pathological features. Respirology 18 : 480-487, 2013.
  pubmed

• 7) Fujinaga Y, et al : Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 76 : 228-238, 2010.
  pubmed

• 8) Matsui S, et al : IgG4-related lung disease. In : IgG4-related disease. p163-168. Springer, Tokyo, 2014.

• 9) Shrestha B, et al : Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis : report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 33 : 1450-1462, 2009.
  pubmed

• 10) 岡崎和一, 他 : IgG4関連疾患包括診断基準2011. 日内会誌 101 : 795-804, 2012.

• 11) 日本膵臓学会・厚生労働省難治性膵疾患に関する調査研究班 : 自己免疫性膵炎臨床診断基準2011. 膵臓 27 : 17-25, 2012.
  Medical*Online

• 12) Kawano M, et al : Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 25 : 810-819, 2011.

• 13) 岡崎和一, 他 : IgG4関連硬化性胆管炎臨床診断基準2012. 胆道 26 : 59-63, 2012.

• 14) Fujimoto M, et al : Storomal plasma cells expressing immunoglobulin G4 subclass in non-small cell lung cancer. Human Pathol 44 : 1569-1576, 2013.

• 15) Masaki Y, et al : Cutoff values of serumIgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012, Article ID 580814, 5 pages, doi : 10.1155/2012/580814.

• 16) Kamisawa T, et al : Standard steroid treatment for autoimmune pancreatitis. Gut 58 : 1504-1507, 2009.
  pubmed

• 17) Khosroshahi A, et al : Rituximab for the treatment of IgG4-related disease : lessons from 10 consecutive patients. Medicine (Baltimore) 91 : 57-62, 2012.
  pubmed

• 18) Murakami J, et al : Recurrence of IgG4-related disease following treatment with rituximab. Mod Rheumatol 23 : 1226-1230, 2013.
  pubmed

• 19) Shiokawa M, et al : Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 108 : 610-617, 2013.
  pubmed

• 20) Zen Y, et al : Th2 and regulatory immune reaction are increased in immunoglobulin G4-related sclerosing Pancreatitis and cholangitis. Hepatology 45 : 1538-1546, 2007.
  pubmed

• 21) 松井祥子 : IgG4関連疾患の肺病変. 日胸臨 67 : 378-386, 2008.
  Medical*Online

P.133 掲載の参考文献

• 1) Panoskaltsis-Mortari A, et al : An offlcial american thoracic society research statement : Non infectious lung injury after hematopoietic stem cell transplantation : Idiopathic pneumonia syndrome. Am J Respir Crit Care Med 183 : 1262-1279, 2011.

• 2) 今泉和良他 : 移植後の閉塞性細気管支炎・肺病変の診断・治療. 日胸臨 69 (10) : 915-923, 2010.
  Medical*Online

• 3) Estenne M, et al : Bronchiolitis obliterans syndrome 2001 : An update of the diagnostic criteria. J Heart Lung Transplant 21 : 297-310, 2002.
  pubmed

• 4) Filipovich A H, et al : National lnstitutes of Health consensus deelopment project on criteria for clinical trials in chronic graft-versus-host disease : 1. Diagnosis and staging working group report Biol Blood Marrow Transplant 11 : 945-956, 2005.

P.141 掲載の参考文献

• 1) Benito N, et al : Pulmonary infections in HIV-infected patients : an update in the 21st century. Eur Respir J 39 (3) : 730-745, 2012.
  pubmed

• 2) 厚生労働科学研究費補助金エイズ対策研究事業「ART早期化と長期化に伴う日和見感染症への対処に関する研究 (安岡班)」平成25年研究成果. 2014年3月.

• 3) Feikin D R, et al : Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 4 (7) : 445-455, 2004.
  pubmed

• 4) Gordin F M, et al : Pneumonia in HIVinfected persons : increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 178 (6) : 630-636, 2008.
  pubmed

• 5) Janoff E N, et al : Pneumococcal disease during HIV infection : epidemiologic, clinical and immunologic perspectives. Ann Intern Med 117 (4) : 314-324, 1992.
  pubmed

• 6) Watanabe T, et al : Serum (1→3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis 49 (7) : 1128-1131, 2009.

• 7) Turner D, et al : Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients : new data, new issues. Eur Respir J 21 (2) : 204-208, 2003.
  pubmed

• 8) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents : recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. (Last updated : 7/8/2013 ; last reviewed : 7/8/2013) Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf

• 9) Center for Disease Control and Prevention : Managing drug interactions in the treatment of HIV-related tuberculosis. June 2013. Available at http://www.cdc.gov/tb/publications/guidelines/tb_hiv_drugs/PDF/tbhiv.pdf

• 10) Department of Health and Human Services (DHHS). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. (Last updated 5/1/2014 ; last reviewed 5/1/2014) Available at http://aidsinfo.nih.gov/guidelines

• 11) 日本結核病学会 : 結核診療ガイドライン改訂第2版. 南江堂, 東京, 2012.

• 12) 日本結核病学会予防委員会・治療委員会 : 潜在性結核感染症治療指針. 結核 88 (5) : 497-512, 2013.
  Medical*Online

• 13) Kirk G D, et al : HIV infection in the etiology of lung cancer : confounding, causality, and consequences. Proc Am Thorac Soc 8 (3) : 326-332, 2011.
  pubmed

第4章 その他の全身性疾患による肺病変

P.147 掲載の参考文献

• 1) Hunninghake G W, et al : ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (1) : 149-173, 1999,

• 2) 日本サルコイドーシス/肉眼腫性疾患学会, 日本呼吸器学会, 他 : サルコイドーシス治療に関する見解-2003. 日サ会 23 (1) : 105-114, 2003.

• 3) Baughman R P, et al : A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 183 (5) : 573-581, 2011.
  pubmed

• 4) Nishimura K, et al : Pulmonary sarcoidosis : correlation of CT and histopathologic findings. Radiology 189 (3) : 105-109, 1993.

• 5) Park H J, et al : Typical and atypical manifestations of intrathoracic sarcoidosis. Korean J Radiol 10 (6) : 623-631, 2009.
  pubmed

• 6) 四十坊典晴, 他 : びまん性肺疾患の画像-多彩なプロファイル-Topicsサルコイドーシス-難治例とその画像-. 日呼吸誌 2 (5) : 512-516, 2013.

• 7) Johns C J, et al The clillical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine 78 (2) : 65-111, 1999.

• 8) 安藤正幸, 他監 : サルコイドーシスとその他の肉芽腫性疾患克誠堂出版東京, 2006.

P.158 掲載の参考文献

• 1) Jaksch-Wartenhorst R : Polychondropathia. Wien Arch Inn Med 6 : 93-100, 1923.

• 2) Pearson C M, et al : Relapsing polychondritis. N Engl J Med 263 : 51-58, 1960.
  pubmed

• 3) McAdam L P, et al : Relapsing polychondritis : prospective study of 23 patients and a review of literature. Medicine 55 : 193-215, 1976.

• 4) Damiani J M, et al : Relapsing polychondritis-report of ten cases. Laryngoscope 89 : 929-946, 1979.
  pubmed

• 5) Michet C J Jr, et al : Relapsing Polychondritis. Survival and predictive role of early desease manifestations. Ann Intern Med 104 : 74-78, 1986.

• 6) Trentham D E, et al : Relapsing polychondritis. Ann Intern Med 129 : 114-122, 1998.
  pubmed

• 7) Kong K O, et al : Relapsing polychondritis-an Oriental case series. Singapore Med J 44 : 197-200, 2003.
  pubmed

• 8) Sharma A, et al : Relapsing polychondritis in North India : a report of 10 patient. Scand J Rheumatol 36 : 462-465, 2007.
  pubmed

• 9) 岡寛, 他 : 再発性多発軟骨炎の全国疫学調査. リウマチ科 44 : 381-383, 2010.

• 10) Piette J C, et al : Relapsing polychondritis. In : Kelley's Textbook of Rheumatology. 8th edition (Kinberly M, ed), p1629-1634. Elsevier, Canada, 2009.

• 11) 梅原久範 : 再発性多発性軟骨炎. 日内会誌 99 : 2467-2471, 2010.

• 12) Terato K, et al : Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 33 : 1493-1500, 1990.
  pubmed

• 13) Foidart J M, et al : Antibodies to type II collagen on relapsing polychondritis. N Engl J Med 299 : 1203-1207, 1978.
  pubmed

• 14) Mohsenifar Z, et al : Pulmonary function in patients with relapsing polychondritis. Chest 81 : 711-717, 1982.
  pubmed

• 15) Sarodia B D, et al : Management of airway manifestations of relapsing polychondritis. Case reports and review of literature. Chest 116 : 1669-1675, 1999.
  pubmed

• 16) 東直人 : 再発性多発軟骨炎における気道病変の臨床. 日臨免疫会誌 35 : 157-167, 2012.

• 17) 祖開暁彦, 他 : 気管気管支に限局した再発性多発軟骨炎の1例. 気管支学 34 : 267-273, 2012.
  Medical*Online

• 18) 安武哲生, 他 : Virtual bronchoscopyで観察評価し得た再発性多発軟骨炎の1例. 日呼吸会誌 48 : 86-91, 2010.
  Medical*Online

• 19) Sato M, et al : F-18 FDG PET/CT in relapsing polychondritis. Ann Nucl Med 24 : 687-690, 2010.
  pubmed

P.168 掲載の参考文献

• 1) Seyama K, et al : Lymphangioleiomyomatosis : a disease involving the lymphatic system. Lymphat Res Biol 8 : 21-31, 2010.
  pubmed

• 2) 林田美江 : LAMの疫学・病像. 呼吸と循環58 (12) : 1211-1216, 2010.

• 3) Carsilo T, et al : Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis, Proc Natl Acad Sci USA 97 : 6085-6090, 2000.

• 4) Karbowniczek M, et al : Recurrent lymphangiomyomatosis after transplantation : genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 167 : 976-982, 2013.

• 5) Badri K R, et al : Exonic mutations of TSC2/TSC1 are commoll but not seen in all sporadic pulmonary lymphangioleiomyomatosis. Am J Respir Crit Care Med 187 : 663-665, 2013.

• 6) Kumasaka T, et al : Lymphangiogenesis-mediated shedding of LAM cell clusters as amechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol 29 : 1356-1366, 2005.

• 7) Mitani K, et al : Cytologic, immunocytochemical and ultrastructural characterization of lymphangioleiomyomatosis cell clusters in chylous effusions of patients with lymphangioleiomyomatosis. Acta Cytol 53 : 402-409, 2009.
  pubmed

• 8) 林田美江, 他 : リンパ脈管筋腫症lymphangioleiomyomatosis (LAM) 診断基準. 日呼吸会誌 46 (6) : 425-427, 2008.
  Medical*Online

• 9) 林田美江, 他 : 特定疾患治療研究事業対象疾患リンパ脈管筋腫症 (LAM) 認定基準の解説. 日呼吸会誌 49 (2) : 67-74, 2011.

• 10) McCormack F X, et al : Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364 : 1595-606, 2011.
  pubmed

• 11) Taveira-DaSilva A M, et al : Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med 154 : 797-805, 2011.
  pubmed

• 12) Bissler J J, et al : Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358 : 140-151, 2008.

• 13) Suina K, et al : Whats the role of sirolimus on the treatment of lymphangioleiomyomatosis (LAM) ? : Merely tuning up of LAM-associated dysfunctional lymphatic vessels rather than cytoreduction? Respir Investig 52 : 274-276, 2014.
  pubmed

• 14) 林田美江, 他 : リンパ脈管筋腫症lymphangioleiomyomatosis (LAM) の治療と管理の手引き. 日呼吸会誌 46 (6) 428-431, 2008.
  Medical*Online

• 15) Ando K, et al : The efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis. Respir Invest 51 : 175-178, 2013.

• 16) McCormack F X, et al : The MILES Trial : Effect of menopausal status on disease progression and treatment responses in lymphangioleiomyomatosis. Am J Respir Crit Care Med 185 : A4442, 2012.

• 17) Hoshika Y, et al : Prevalence and clinical features of lymphedema in patients with lymphangioleiomyomatosis. Respir Med 107 : 1253-1259, 2013.
  pubmed

• 18) Yamakado K, et al : Renal angiomyolipoma : relationships between tumor size, aneurysm formation, and rupture. Radiology 225 : 78-82, 2002.
  pubmed

• 19) Hayashida M, et al : The epidemiology of lymphangioleiomyomatosis in Japan : a nationwide cross-sectional study of presenting features and prognostic factors. Respirology 12 : 523-530, 2007.
  pubmed

P.175 掲載の参考文献

• 1) Lichtenstein L : Histiocytosis X ; integration of eosinophilic granuloma of bone, Letter-Siwe disease, and SchUller-Christian disease ad related manifestations of a single nosologic entity. AMA Arch Pathol 56 : 84-102, 1953.

• 2) 岩井和郎 : 肺の好酸球性肉芽腫の1例. 日臨 15 : 2015-2019, 1957.

• 3) 浅本仁, 他 : わが国における肺好酸球性肉芽腫症17症例についての臨床的分析. 日胸疾患会誌 33 : 1372-1381, 1995.

• 4) Watanabe R, et al : Clinico-epidemiological features of pulmonary histiocytosis X. Intern Med 40 (10) : 998-1003, 2001.
  pubmed

• 5) Gaensler E, et al : Open biopsy for chronic diffuse infiltrative lung disease : clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 30 : 411-426, 1980.
  pubmed

• 6) 井上義一, 他 : 平成21年度厚生労働省科学研究費補助金難治性疾患克服研究事業報告書, 2010.

• 7) Arico M, et al : Langerhans cell histiocytosis in two fenerations : a new family and review of the literature. Med Pediatr Oncol 36 : 314-316, 2001.
  pubmed

• 8) Vassallo R, et al : Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 342 : 1969-1978, 2000.
  pubmed

• 9) Tazi A : Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 27 : 1056-1065, 2006.

• 10) Howarth D M, et al : Langerhans cell histiocytosis : diagnosis, natural history, management, and outcome. Cancer 85 (10) : 2278-2290, 1999.
  pubmed

• 11) Auerswald U, et al : Value of CD-1-positive cells in bronchoalveolar lavage fiuid for the diagnosis of pulmonary histiocytosis X. Lung 169 : 305-309, 1991.

• 12) Travis W D, et al : Pulmonary Langerhans cell granulomatosis (Histiocytosis X) A clinicopathologic study of 48 cases. Am J Surg Pathol 17 : 971-986, 1993.
  pubmed

• 13) Vassallo R, et al : Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 346 : 484-490, 2002.
  pubmed

第5章 他臓器疾患の肺病変

P.181 掲載の参考文献

• 1) Greenstein A J, et al : The extra-intestinal complications of Crohn's disease and ulcerative colitis : a study of 700 patients. Medicine 55 : 401-412, 1976.
  pubmed

• 2) Camus P, et al : The lung in inflammatory bowel disease. Eur Respir J 15 : 5-10, 2000.
  pubmed

• 3) Black H, et al : Thoracic manifestations of inflammatory bowel disease. Chest 131 : 524-532, 2007.
  pubmed

• 4) Hamada S, et al : Effect of inhaled corticosteroid therapy on CT scan-estimated airway dimensions in a patient with chronic bronchitis related to ulcerative colitis. Chest 139 : 930-932, 2011.

• 5) Takeda S, et al : Two patients with new granulomatous lung lesions during treatment of Crohn's disease. Respir Med Case Reports 12 : 16-18, 2014.

• 6) Shad J A, et al : Tracheobronchitis as an initial presentation of ulcerative colitis. J Clin Gastroenterol 33 : 161-163, 2001.
  pubmed

• 7) Bernstein C N, et al : The clustering of other chronic in且ammatory bowel diseases in inflammatory bowel disease : a population-based study. Gastroenterology 129 : 827-836, 2005.

• 8) Louis E, et al : Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 29 : 729-733, 1999.

• 9) Ceyhan B B, et al : Bronchial hyperreactivity and allergic status in inflammatory bowel disease. J Clin Gastroenterol 37 : 292-298, 2003.

• 10) Inoue N, et al : Restricted V (H) gene usage in lamina propria B cells producing anticolon antibody from patients with ulcerative colitis. Gastroenterology 121 : 15-23, 2001,

• 11) Kamada N, et al : Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175 : 6900-6908, 2005.
  pubmed

• 12) Okazawa A, et al : Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement. Am J Gastroenterol 97 : 3108-3117, 2002.
  pubmed

• 13) Fidler H M, et al : Specific detection of Mycobacterium paratuberculosis DNA associated with granuloma tissue in Crohn's disease. Gut 35 : 506-510, 1994.
  pubmed

• 14) Colombel J F, et al : Infliximab, azathioprine, or combination therapy fbr Crohn's disease. N Engl J Med 362 : 1383-1395, 2010.

• 15) Danese S, et al : Review article : the role of anti-TNF in the management of ulcerative colitis-past, present and future. Aliment Pharmacol Ther 37 : 855-866, 2013.
  pubmed

• 16) Takeuchi T, et al : Postmarketing surveillance of the safety profile of infiximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 67 : 189-194, 2008.

• 17) Koike T, et al : Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients : postmarketing surveillance report of 7740 patients. Mod Rheumatol 24 : 390-398, 2014.
  pubmed

P.189 掲載の参考文献

• 1) Vakil N, et al : The Montreal definition and classification of gastroesophageal reflux disease : a global evidence-based consensus. Am J Gastroenterol 101 : 1900-1920, 2006.
  pubmed

• 2) 日本呼吸器学会咳嗽に関するガイドライン第2版作成委員会編 : 咳嗽に関するガイドライン第2版. 日本呼吸器学会, 東京, 2012.

• 3) Irwin R S, et al : Chronic cough due to gastroesophageal reflux disease : failure to resolve despite total/near-total elimination of esophageal acid. Chest 121 : 1132-1140, 2002.
  pubmed

• 4) Havemann B D, et al : The association between gastro-oesophageal reflux disease and asthma : a systematic review. Gut 56 : 1654-1664, 2007.
  pubmed

• 5) ten Brinke A, et al : Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 26 : 812-818, 2005.
  pubmed

• 6) Kiljander T O, et al : Effects of esomeprazole 40mg twice daily on asthma : arandomized placebo-controlled trial. Am J Respir Crit Care Med 173 : 1091-1097, 2006.

• 7) Littner M R, et al : Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 128 : 1128-1135, 2005.

• 8) Chan W W, et al : The ethcacy of proton pump inhibitors for the treatment of asthma in adults : a meta-analysis. Arch Intern Med 171 : 620-629, 2011.
  pubmed

• 9) 喘息予防・管理ガイドライン2012作成委員編 : 喘息予防・管理ガイドライン2012. 日本アレルギー学会, 東京, 2012,

• 10) Mays E E, et al : Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal refiux in interstitial pulmonary fibrosis of obscure etiology. Chest 69 : 512-515, 1976.

• 11) Raghu G, et al : High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 27 : 136-142, 2006.
  pubmed

• 12) Savarino E, et al : Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J 42 : 1322-1331, 2013.
  pubmed

• 13) Lee J S, et al Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J 39 : 352-358, 2012.
  pubmed

• 14) Linden P A, et al : Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 131 : 438-446, 2006.
  pubmed

• 15) Lee J S, et al : Gastroesophageal refiux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184 : 1390-1394, 2011.

• 16) Casanova C, et al : Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J 23 : 841-845, 2004.
  pubmed

• 17) Phulpoto M A, et al : Proportion of gastroesophageal refiux symptoms in patients with chronic obstructive pulmonary disease. J Pak Med Assoc 55 : 276-279, 2005.

• 18) Wedzicha J A, et al : Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 11 : 181, 2013.
  pubmed

• 19) Sasaki T, et al : A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc 57 : 1453-1457, 2009.

• 20) el-Serag H B, et al : Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 113 : 755-760, 1997.
  pubmed

• 21) Lee A L, et al : Gastro-oesophageal reflux in noncystic fibrosis bronchiectasis. Pulm Med 2011.
  pubmed

• 22) Koh W J, et al : Prevalence of gastroesophageal refiux disease in patients with nontuberculous mycobacterial lung disease. Chest 131 : 1825-1830, 2007.

P.197 掲載の参考文献

• 1) 大山優 : 神経内分泌腫瘍. What's new in Oncology癌治療エッセンシャルガイド (佐藤隆美, 他監), p487-498. 南山堂, 東京, 2010.

• 2) Soga J, et al : Bronchopulmonary carcinoids : An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 5 (4) : 211-219, 1999.
  pubmed

• 3) Travis W D, et al : Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15 (6) : 529-553, 1991.
  pubmed

• 4) Asamura H, et al : Neuroendocrine neoplasms of the lung : A prognostic spectrum. J Clin Oncol 24 : 70-76, 2006.

• 5) Wirth L J, et al : Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy. Lung Cancer 44 (2) : 213-220, 2004.

• 6) 横山雅大 : 腫瘍随伴症候群. 新臨床腫瘍学 (日本臨床腫瘍学会監). P603-607. 南江堂, 東京, 2012.

• 7) Comis R L, et al : Abnormalities in water horneostasis in small cell anaplastic lung cancer. Cancer 45 (9) : 2414-2421, 1980.
  pubmed

• 8) 朝戸裕子, 他 : 特発性中枢性尿崩症に肺癌を合併し, 多尿の診断と治療に苦慮した一例. 日呼吸誌 3 (3) : 385-389, 2014.

• 9) Halpert B, et al : Intracranial involvement from carcinoma of the lungs. Arch Pathol 69 : 93-103, 1960.
  pubmed

• 10) Teears R J, et al : Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland. Cancer 36 (1) : 216--220, 1975.

• 11) 西澤依小, 他 : 両側副腎転移によりAddison病を来たした肺腺癌の一例. 肺癌 40 (6) : 623-627, 2000.

• 12) Shames R S, et al : Clinical differences among women with and without self-reported perimenstrual asthma Ann Allergy Asthma Immunol 81 (1) : 65-72, 1998.
  pubmed

• 13) 鰤岡直人 : 内分泌疾患と肺. 呼吸器科 2 (5) : 391-394, 2002.

• 14) Nagata K, et al : Increased theophylline metabolism in the menstrual phase of healthy women. J Allergy Clin Immunol 100 : 39-43, 1997.
  pubmed

• 15) Haga T, et al : Thoracic Endometriosis-Related Pneumothorax Distinguished From Primary Spontaneous Pneumothorax in Females. Lung 192 (4) : 583-587, 2014
  pubmed

• 16) 高橋源 : Pro-gastrin-releasing peptide (pro-GRP) 高値を呈した孤立性肺定型カルチノイドの3例. 日呼吸誌 3 (3) : 432-437, 2014.

P.204 掲載の参考文献

• 1) Benditt J O, et al : Pulmonary issues in patients with chronic neuromuscular disease. Am I Respir Crit Care Med 187 : 1046-1055, 2013.

• 2) Mehta S : Neuromuscular disease causing acute respiratory failure. Respir Care 51 : 1016-1021, 2006.
  pubmed

• 3) Braun N M T, et al : respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 38 : 316-323, 1983.

• 4) Carratu P, et al : Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis : Preliminary results. Amyotroph Lateral Scler 12 : 458-463, 2011.
  pubmed

• 5) Morgan R K, et al : use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crt Care Med 171 : 269-274, 2005.

• 6) Lechtzin N, et al : Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 121 : 436-442, 2002.
  pubmed

• 7) Schmidt E P, et al : Pulmonary predictors of survival in amyotrophic lateral sclerosis. Muscle Nerve 33 : 127-132, 2006.
  pubmed

• 8) Lechtzin N, et al : Early use of non-invasive ventilation in Duchenne muscular dystrophy. Amyotorph Lateral Scler 8 : 185-188, 2007.

• 9) Estenne M, et al : Chest wall stiffness in patients with chronic respiratory muscle weakness. Am Rev Respir Dis 128 : 1002-1007, 1983.
  pubmed

• 10) Kirk V : Pulmonary complications of neuromuscular disease. Paediatr Respir Rev 7 (S) : S232-242, 2006.
  pubmed

• 11) Annane D, et al : Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur Respir J 13 : 157-162, 1999.
  pubmed

• 12) Goldstein R S, et al : reversal of sleep-induced hypoventilation and chronic respiratory failure by nocturnal negative pressure ventilation in patients with restrictive ventilator impairment Am Rev Respir Dis 135 : 1049-1055, 1987.
  pubmed

• 13) Ragette R, et al : Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 57 : 724-728, 2002.
  pubmed

• 14) Bach J R, et al : Criteria for extubation and tracheostomy tube removal for patients with ventilator failure : a different approach to weaning. Chest 110 : 1566-1571, 1996.
  pubmed

• 15) Lechtzin N, et al : Supramaximal infiation improves lung compliance in subjects with amyotrophic lateral sclerosis. Chest 129 : 1322-1329, 2006.

• 16) Mckim D A, et al : Canadian Thoracic Society Home Mechanical Ventilation Committee. Home mechanical ventilation : a Canadian Thoracic Society clinical practice guideline. Can Respir J 18 : 197-215, 2011.
  pubmed

• 17) Servera E, et al : Non-invasive management of an acute chest infection for a patients with ALS. J Neurol Sci 209 : 111-113, 2003.
  pubmed

• 18) Tilton A H, et al : Nutrition and swallowing in pediatric neuromuscular patients. Semin Pediatr Neurol 5 : 106-115, 1998.
  pubmed

• 19) Miller R G, et al : Practice parameter : the care of the patient with amyotrophic lateral sclerosis (an evidence based review) : report of the Quality Standard Subcommittee of the American Academy of Neurology : ALS Practice Parameters Task Force. Neurology 52 : 1311-1323, 1999.

• 20) 石川悠加, 他 : 慢性呼吸不全に対する非侵襲的換気療法ガイドライン-神経筋疾患. Ther Res 25 : 37-41, 2004.